Study of Speech Function in Epileptic Patients Based on Stereoelectroencephalography Signal
Primary Purpose
Epilepsy
Status
Active
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Speech
Stereoelectroencephalography
Sponsored by
About this trial
This is an interventional basic science trial for Epilepsy focused on measuring Epilepsy, Stereoelectroencephalography, Speech
Eligibility Criteria
Inclusion Criteria: Patients with focal refractory epilepsy also need preoperative evaluation with SEEG Exclusion Criteria: History of major depression or psychiatric disorders and medication that causes symptoms of psychiatric disorders Patients with severe cognitive impairment (MMSE score ≤15), unable to complete the language function test
Sites / Locations
- Zhejiang University School of Medicine Second Affiliated Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Epileptic
Arm Description
Epileptic with stereoelectroencephalography
Outcomes
Primary Outcome Measures
Phonetic Feature Encoding in Human Superior Temporal Gyrus
Phonetic Feature Encoding in Human Superior Temporal Gyrus
Secondary Outcome Measures
Full Information
NCT ID
NCT05776745
First Posted
February 7, 2023
Last Updated
March 8, 2023
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
1. Study Identification
Unique Protocol Identification Number
NCT05776745
Brief Title
Study of Speech Function in Epileptic Patients Based on Stereoelectroencephalography Signal
Official Title
Study of Speech Function in Epileptic Patients Based on Stereoelectroencephalography Signal
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 20, 2022 (Actual)
Primary Completion Date
October 20, 2022 (Actual)
Study Completion Date
December 25, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Based on stereoelectroencephalography model in the treatment of epilepsy patients, this study conducted language-related experimental studies without interfering with normal monitoring treatment. Meanwhile, voice data and intracranial electrophysiological data were collected for analysis. To study the mechanism related to the language function of patients, try to establish a model to decode the intracranial electrophysiological data related to language.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Epilepsy
Keywords
Epilepsy, Stereoelectroencephalography, Speech
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Epileptic
Arm Type
Experimental
Arm Description
Epileptic with stereoelectroencephalography
Intervention Type
Behavioral
Intervention Name(s)
Speech
Intervention Description
Patients read specific words and sentences
Intervention Type
Device
Intervention Name(s)
Stereoelectroencephalography
Intervention Description
Using stereoelectroencephalography to record the Intracranial EEG of the patient
Primary Outcome Measure Information:
Title
Phonetic Feature Encoding in Human Superior Temporal Gyrus
Description
Phonetic Feature Encoding in Human Superior Temporal Gyrus
Time Frame
through study completion, an average of 1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with focal refractory epilepsy also need preoperative evaluation with SEEG
Exclusion Criteria:
History of major depression or psychiatric disorders and medication that causes symptoms of psychiatric disorders
Patients with severe cognitive impairment (MMSE score ≤15), unable to complete the language function test
Facility Information:
Facility Name
Zhejiang University School of Medicine Second Affiliated Hospital
City
Hangzhou
State/Province
Zhejiang
ZIP/Postal Code
310009
Country
China
12. IPD Sharing Statement
Learn more about this trial
Study of Speech Function in Epileptic Patients Based on Stereoelectroencephalography Signal
We'll reach out to this number within 24 hrs